Pricing Log in Create free account

Akso Health Group Sponsored ADR (AHG) vs Cellyan Biotechnology Co., Ltd (HKPD)

Akso Health Group Sponsored ADR and Cellyan Biotechnology Co., Ltd are both Medical Distribution companies. Akso Health Group Sponsored ADR is the larger, with a market value of $1.1B against $3.4M — 331.3× the size. Across the 5 metrics below, Cellyan Biotechnology Co., Ltd leads on 3 and Akso Health Group Sponsored ADR on 2.

Valuation

Metric AHG HKPD Medical Distribution median
P/E n/m — —
P/S 1.05 — 0.27
P/B 0.11 n/m —
Price to free cash flow n/m n/m —
EV/EBITDA n/m n/m 17.33
EV/Sales 1.72 n/m 0.86
Earnings yield (13.85%) — (13.85%)
Free cash flow yield (757.58%) 0.00% (6.11%)

Profitability

Metric AHG HKPD Medical Distribution median
Gross margin 0.00% — 5.74%
Operating margin 0.00% — 0.00%
Net margin (61.29%) — (11.41%)
Free cash flow margin 0.00% 0.00% (0.36%)
Return on equity 0.00% 0.00% 0.00%
Return on assets 0.00% 0.00% (1.95%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AHG HKPD Medical Distribution median
Revenue growth (TTM) 208.41% — 6.15%
EPS growth (last fiscal year) 102.10% (2,521.89%) 5.18%
Revenue growth, 5-year CAGR 51.12% — 8.18%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AHG HKPD Medical Distribution median
Debt to equity 0.00 0.10 (0.66)
Current ratio 1.53 3.86 0.99
Net debt to EBITDA (0.01) (0.79) (0.10)

Dividend

Metric AHG HKPD Medical Distribution median
Dividend yield — — —
Payout ratio — — —

Size

Metric AHG HKPD Medical Distribution median
Market cap 1.11b 3.35m 97.81m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack